4//SEC Filing
ProPhase Labs, Inc. 4
Accession 0001144204-15-036100
$PRPHCIK 0000868278operating
Filed
Jun 7, 8:00 PM ET
Accepted
Jun 8, 5:23 PM ET
Size
7.7 KB
Accession
0001144204-15-036100
Insider Transaction Report
Form 4
Leventhal Mark S
10% Owner
Transactions
- Award
Common Stock, par value $0.0005
2015-06-05$1.31/sh+128,529$168,373→ 410,509 total - Award
Common Stock, par value $0.0005
2015-06-08$1.40/sh+71,471$100,059→ 481,980 total
Holdings
- 180,000(indirect: By Foundation)
Common Stock, par value $0.0005
Footnotes (3)
- [F1]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.30 to $1.39, inclusive.
- [F2]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.38 to $1.40, inclusive.
- [F3]The reporting person and his wife control the Mark S & Donna R Leventhal Family Foundation Inc., a charitable foundation. The reporting person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.
Documents
Issuer
ProPhase Labs, Inc.
CIK 0000868278
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0000868278
Filing Metadata
- Form type
- 4
- Filed
- Jun 7, 8:00 PM ET
- Accepted
- Jun 8, 5:23 PM ET
- Size
- 7.7 KB